Singapore, Dec. 6 -- Australia's onshore vaccine manufacturing capabilities took a leap forward as Mark Butler MP, Minister for Health, Disability and Ageing, opened CSL Seqirus' state-of-the-art cell-based influenza vaccine and antivenom manufacturing facility in Melbourne.

The Australian-owned and operated facility uses innovative technology to manufacture seasonal and pandemic flu vaccines for Australia and the world. It is the only cell-based influenza vaccine manufacturing facility in the Southern Hemisphere and makes Australia one of only three countries globally with the end-to-end capability to make advanced cell-based influenza vaccines.

It is also the only manufacturing site in the world capable of producing Australia's eleven...